Michael Burke has taken a stake in a firm that will seek to acquire or invest in early stage food and wellness businesses

Dublin-based biotech investment fund said €45 million of the proceeds from the sale will be used to repay a European Investment Bank loan, with the remaining cash to be returned to shareholders later this year

The Dublin company is in discussion with regulators in Britain and France to have metreleptin, a treatment for abnormal distribution of fat in the body, approved for payment reimbursement

Clinical trials firm reported 10.8% drop in revenues for the three months to the end of June

We have the potential to become Europe’s go-to destination for the development of advanced therapy medicinal products

The essential ingredients for common drugs are largely produced in the countries worst-hit by Covid-19. We could soon be facing shortages of antibiotics, paracetamol, statins and other medication

Zoetis, the animal pharma giant, has acquired exclusivity on Stablelab, a hand-held test that quickly assesses the severity of infections in horses

Friel ready to stump up €3m of fundraising for purchase of British clinical trials firm

Dublin-based healthcare group buys US agency Canale Communications for up to $31m

A former worker at the US firm‘s Shannon plant claims his Parkinson’s disease is linked to exposure to dangerous chemical

The pharmaceutical industry wants future negotiations on drug pricing to include the extent to which drugs prevent costly hospital stays and details of other societal benefits they generate